• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adult's Lived Experience Using the Insulin-Only Bionic Pancreas.成人使用仅胰岛素的仿生胰腺的生活体验。
J Diabetes Sci Technol. 2025 Jan;19(1):11-17. doi: 10.1177/19322968241274364. Epub 2024 Aug 30.
2
Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas.家长、儿童和青少年使用仅胰岛素的 iLet 仿生胰腺的生活体验。
J Pediatr Psychol. 2024 Jun 13;49(6):413-420. doi: 10.1093/jpepsy/jsae022.
3
Experiences and opinions of adults with type 1 diabetes on the android-based open-source closed-loop system in China: a qualitative study.中国1型糖尿病成人患者对基于安卓系统的开源闭环系统的体验与看法:一项定性研究
BMJ Open. 2025 Jan 15;15(1):e094333. doi: 10.1136/bmjopen-2024-094333.
4
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.1型糖尿病成人患者使用双激素仿生胰腺与胰岛素泵治疗的家庭应用:一项多中心随机交叉试验。
Lancet. 2017 Jan 28;389(10067):369-380. doi: 10.1016/S0140-6736(16)32567-3. Epub 2016 Dec 20.
5
Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes.《1 型糖尿病成人自动化胰岛素输送:益处和负担量表的心理测量特性》。
Diabetes Technol Ther. 2024 Nov;26(11):842-850. doi: 10.1089/dia.2024.0117. Epub 2024 May 31.
6
Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trial.一项随机、开放标签临床试验的研究方案,旨在评估 Android 人工胰腺系统(AAPS)在 1 型糖尿病成人患者中的安全性和有效性,该系统具有先进的无推注功能:“CLOSE IT”(闭环开源 1 型糖尿病)试验。
BMJ Open. 2024 Feb 20;14(2):e078171. doi: 10.1136/bmjopen-2023-078171.
7
Analysis of "Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes".分析“使用自制人工胰腺系统的混合闭环在 1 型糖尿病成人中的应用”。
J Diabetes Sci Technol. 2024 Jul;18(4):897-898. doi: 10.1177/19322968231208216. Epub 2023 Oct 18.
8
The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.仅胰岛素的仿生胰腺关键试验扩展研究:在成人和青少年 1 型糖尿病患者中对仿生胰腺仅胰岛素配置的多中心单臂评估。
Diabetes Technol Ther. 2022 Oct;24(10):726-736. doi: 10.1089/dia.2022.0341.
9
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.多中心、随机对照试验:仿生胰腺在 1 型糖尿病中的应用。
N Engl J Med. 2022 Sep 29;387(13):1161-1172. doi: 10.1056/NEJMoa2205225.
10
Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting.家用单胰岛素仿生胰腺的可行性研究。
J Diabetes Sci Technol. 2019 Nov;13(6):1001-1007. doi: 10.1177/1932296819872225. Epub 2019 Aug 30.

引用本文的文献

1
Psychosocial Aspects of Diabetes Technologies: Commentary on the Current Status of the Evidence and Suggestions for Future Directions.糖尿病技术的社会心理层面:证据现状述评与未来方向建议
J Diabetes Sci Technol. 2025 Jan;19(1):27-33. doi: 10.1177/19322968241276550. Epub 2024 Oct 21.

本文引用的文献

1
Psychosocial Impact of the Insulin-Only iLet Bionic Pancreas for Adults, Youth, and Caregivers of Youth with Type 1 Diabetes.胰岛素-only iLet 仿生胰腺对成年、青少年及青少年 1 型糖尿病患者照护者的心理社会影响。
Diabetes Technol Ther. 2023 Oct;25(10):705-717. doi: 10.1089/dia.2023.0238. Epub 2023 Sep 5.
2
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.多中心、随机对照试验:仿生胰腺在 1 型糖尿病中的应用。
N Engl J Med. 2022 Sep 29;387(13):1161-1172. doi: 10.1056/NEJMoa2205225.
3
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System.自动化胰岛素输注系统的引入如何影响 1 型糖尿病成人的心理社会结局:使用 Omnipod® 5 系统的首次调查结果。
Diabetes Res Clin Pract. 2022 Aug;190:109998. doi: 10.1016/j.diabres.2022.109998. Epub 2022 Jul 16.
4
Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial.与预测性低血糖暂停相比,在 1 型糖尿病患者中随机交叉试验中,使用美敦力 MiniMed®高级混合闭环输送可提高技术满意度和睡眠质量。
Acta Diabetol. 2022 Jan;59(1):31-37. doi: 10.1007/s00592-021-01789-5. Epub 2021 Aug 27.
5
Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting.在真实临床环境中,使用高级混合闭环系统改善用户体验和血糖控制效果。
Diabetes Res Clin Pract. 2021 Aug;178:108986. doi: 10.1016/j.diabres.2021.108986. Epub 2021 Jul 27.
6
Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives.高级混合闭环与混合闭环的真实体验:患者报告的结果和观点。
Diabetes Technol Ther. 2021 Dec;23(12):857-861. doi: 10.1089/dia.2021.0153. Epub 2021 Oct 26.
7
How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).从何而来,路在何方:人工胰腺系统(自动胰岛素输送系统)的未来。
J Diabetes Sci Technol. 2021 Nov;15(6):1258-1261. doi: 10.1177/19322968211027558. Epub 2021 Jul 5.
8
The Impact of a Recently Approved Automated Insulin Delivery System on Glycemic, Sleep, and Psychosocial Outcomes in Older Adults With Type 1 Diabetes: A Pilot Study.最近批准的自动胰岛素输送系统对老年 1 型糖尿病患者血糖、睡眠和心理社会结局的影响:一项初步研究。
J Diabetes Sci Technol. 2022 May;16(3):663-669. doi: 10.1177/1932296820986879. Epub 2021 Jan 15.
9
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial.《1 型糖尿病成人患者经皮指尖血糖监测的混合闭环与手动胰岛素输注 6 个月的随机对照试验》
Diabetes Care. 2020 Dec;43(12):3024-3033. doi: 10.2337/dc20-1447. Epub 2020 Oct 14.
10
Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.参与者在真实生活环境中对日夜混合闭环系统日间使用的体验和看法:纵向定性研究。
Diabetes Technol Ther. 2019 Mar;21(3):119-127. doi: 10.1089/dia.2018.0306. Epub 2019 Feb 5.

成人使用仅胰岛素的仿生胰腺的生活体验。

Adult's Lived Experience Using the Insulin-Only Bionic Pancreas.

作者信息

Garza Kimberly P, Howard Kelsey R, Feldman Marissa, Weissberg-Benchell Jill

机构信息

Pritzker Department of Psychiatry and Behavioral Health, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Department of Sociology and Public Health Studies, Roanoke College, Salem, VA, USA.

出版信息

J Diabetes Sci Technol. 2025 Jan;19(1):11-17. doi: 10.1177/19322968241274364. Epub 2024 Aug 30.

DOI:10.1177/19322968241274364
PMID:39212346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11571438/
Abstract

BACKGROUND

The purpose of this study was to assess adults' perspectives after using the insulin-only Bionic Pancreas (BP) during a 13-week pivotal trial. Automated insulin delivery (AID) systems show promise in improving glycemic outcomes and reducing disease burden for those with type 1 diabetes mellitus (T1D). Understanding the lived experience of those using the BP can help to inform education and uptake of AID devices.

METHODS

Adults ages 19 to 75 (n = 40) participated in age-specific focus groups (19-25, 26-40, 41-64, and 65+) exploring their experiences, thoughts, and feelings about using the BP. Three authors analyzed the focus group data using a hybrid thematic approach.

RESULTS

Qualitative analysis of focus groups revealed 14 sub-themes falling into four major themes (diabetes burden, managing glucose levels, daily routine, and user experience). Although participants' overall experience was positive, some reported struggles related to managing out-of-range glucose levels and challenges with the system responding to unique meal schedules and exercise regimens.

CONCLUSION

This study captures patient perspectives regarding their experiences with a new AID system. Patient voice can inform device development and educational approaches for people with T1D. Identifying which patients may benefit the most from wearing this system may facilitate patient/clinician discussions regarding insulin delivery systems that best meet their individualized needs and expectations that may support device uptake and continued use.

摘要

背景

本研究的目的是评估成年人在一项为期13周的关键试验中使用仅含胰岛素的仿生胰腺(BP)后的看法。自动胰岛素输送(AID)系统在改善1型糖尿病(T1D)患者的血糖结果和减轻疾病负担方面显示出前景。了解使用BP者的实际体验有助于为AID设备的教育和推广提供信息。

方法

19至75岁的成年人(n = 40)参加了特定年龄的焦点小组(19 - 25岁、26 - 40岁、41 - 64岁和65岁以上),探讨他们使用BP的经历、想法和感受。三位作者采用混合主题方法分析了焦点小组数据。

结果

焦点小组的定性分析揭示了14个亚主题,分为四个主要主题(糖尿病负担、血糖管理、日常生活和用户体验)。尽管参与者的总体体验是积极的,但一些人报告了在管理血糖超出范围方面的困难,以及系统应对独特饮食计划和运动方案时的挑战。

结论

本研究获取了患者对新AID系统体验的看法。患者的声音可为T1D患者的设备开发和教育方法提供信息。确定哪些患者可能从佩戴该系统中获益最大,可能有助于患者/临床医生就最能满足其个性化需求和期望的胰岛素输送系统进行讨论,这可能支持设备的采用和持续使用。